MDB-33. SIOPE-MB6 – THE RATIONALE FOR THE NEXT EUROPEAN STANDARD RISK MEDULLOBLASTOMA PHASE II/III TRIAL
MDB-33. SIOPE-MB6 – 下一阶段欧洲标准风险髓母细胞瘤 II/III 期试验的理论依据
期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000032753
Ji, Yong; Liang, Yi; Liu, Bin; Wang, Yaxin; Li, Ling; Liu, Yan; Feng, Yifan; Dong, Nuo; Xiong, Wei; Yue, Hongli; Jin, Xu; Mynarek, Martin; Doz, Francois; Clifford, Steve C; Bailey, Simon; Rutkowski, Stefan; Padovani, Laeticia; Bouchoucha, Yassine; Partanen, Marita; Verity, Sarah; Sehested, Astrid; Puhr, Anita; Rossius, Anne; Chevignard, Mathilde; Dorfer, Christian; Damaty, Ahmed El; Beccaria, Kevin; Aquilina, Kristian; Hoving, Eelco W; Schuhmann, Martin U; Thomale, Ulrich W; Milde, Till